YAZDANPARAST K, DEHBASHI N, MANSOUR GHANAIE F. CLINICA L FINDINGS IN PATIENTS WITH ACUTE AMEBIC PROCTOCOLITIS A ND EFFICA CY OF COMBINED THERAPY WITH SACCHAROMYCES BOULARDII. Med J Islam Repub Iran 1994; 8 (3) :155-157
URL:
http://mjiri.iums.ac.ir/article-1-1373-en.html
From tile Dept. of Microbiology and the Dept. of Medicine, Shiraz University of Medical Sciences,Shiraz, Islamic Republic of lran
Abstract: (4950 Views)
Intestinal amebiasis has a worldwide distribution and is common in tropical
and subtropical areas. [n this prospective 7-month study, we studied the main
clinical findings in patients with acute amebic proctocolitis and the efficacy of
Saccharomyces boulardii (SB) treatment of these patients.Initially, 57 cases with
acute amebic proctocolitis were selected. The maximum occurrence of infection
was found to be in the 30-39 year old age group. The patients were then randomized
to two therapeutic regimens. The first included metronidazole 750 mg P.O. tid X 1 0
days and iodoquinol630 mg P.O. tid Xl 0 days, and the second was the latter plus
S. boulardii 250 mg P.O. tid x 10 days. The diarrhea, abdominal pain and fever
were significantly decreased after initation of therapy in patients receiving
regimen IT as compared with patients of regimen 1. Four weeks after the end of
treatment, the two groups were examined for carrier states (presence of amebic
cysts in stool, without symptoms). [n regimen I, the percentage of carriers was
[1).4%, but in the patients who received regimen IT, no carriers were found (P=
0.025).